Skip to content
← Full study record

NCT01651039 · MORE INFO

Limitations, agreements, and source contact

Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM) · Source last updated 2018-04-09

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
ajai.chari@mountsinai.org
organization
Icahn School of Medicine at Mount Sinai
phone
212-241-7873
title
Dr. Ajai Chari
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
ajai.chari@mountsinai.org
organization
Icahn School of Medicine at Mount Sinai
phone
212-241-7873
title
Dr. Ajai Chari

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice